Product Follow by RSS
Retatrutide
Experimental triple-hormone-agonist weight-loss drug developed by Eli Lilly
Also: Reta
In 19 articles · first seen · latest
Solid lines: relations reported in articles. Dashed: appear in the same stories. Thicker means more evidence.
Timeline
-
11 Nov 2026 · 1 outlet
Retatrutide trials show reduced knee osteoarthritis pain in obese patients -
2 Nov 2026 · 1 outlet
GP says retatrutide offers hope for patients stuck on Mounjaro -
28 Oct 2026 · 2 outlets
Lilly's retatrutide cut sleep apnea breathing interruptions and weight in two trials -
28 Oct 2026 · 3 outlets
Lilly says retatrutide beat Novo's Ozempic in 80-week type 2 diabetes trial -
13 Oct 2026 · 2 outlets
Two deaths reported to FDA are linked to bootleg retatrutide; cause unverified -
14 Oct 2026 · 1 outlet
Eli Lilly retatrutide trial results and possible availability of the weight-loss drug -
14 Oct 2026 · 1 outlet
Study finds 129 reported symptoms among users of unlicensed retatrutide -
29 Sep 2026 · 6 outlets
Late-stage trials show Lilly's retatrutide cut body weight by up to about a quarter -
30 Sep 2026 · 2 outlets
Real-world study: people switching from weight-loss jabs to Wegovy pill kept losing weight -
30 Sep 2026 · 1 outlet
Retatrutide weight-loss drug shows greater effectiveness than Mounjaro in study